Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Songyang Wu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|September 15, 2023
PICOTEES: a privacy-preserving online service of phenotype exploration for genetic-diagnostic variants from Chinese children cohortsXinran Dong, Yulan Lu, Lanting Guo, et al.
Nature Cancer|February 5, 2022
Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancerMinhong Shen, Heath A Smith, Yong Wei, et al.
Nature Cancer|February 5, 2022
Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasisMinhong Shen, Yong Wei, Hahn Kim, et al.
Eclinicalmedicine|July 24, 2024
Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II studyMin He, Shuang Hao, LinXiaoxi Ma, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|September 15, 2023
PICOTEES: a privacy-preserving online service of phenotype exploration for genetic-diagnostic variants from Chinese children cohortsXinran Dong, Yulan Lu, Lanting Guo, et al.
Nature Cancer|February 5, 2022
Pharmacological disruption of the MTDH-SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancerMinhong Shen, Heath A Smith, Yong Wei, et al.
Nature Cancer|February 5, 2022
Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasisMinhong Shen, Yong Wei, Hahn Kim, et al.
Eclinicalmedicine|July 24, 2024
Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II studyMin He, Shuang Hao, LinXiaoxi Ma, et al.
Pageof 2